The cellular landscape of druggable RNA-binding proteins.

Cell surface RNA-binding proteins are identified with disease-specific and cell-type specificities, offering new avenues for immunotherapy and biomarker development.

• Why it matters: RBPs are central to RNA metabolism and cell identity, and their involvement in disease, especially cancer, highlights the need for targeted therapeutic strategies. Understanding their localization could unlock new diagnostic and treatment options.
• What they did: The study reviews intracellular functions of RBPs, their disease associations, particularly in cancer, and explores the emerging field of cell surface RBPs, emphasizing strategies to utilize their surface localization for immunotherapeutic development.
• The result: This work suggests that cell surface RBPs could serve as biomarkers and immunotherapy targets, potentially enabling the development of novel therapeutic modalities for various diseases.